cilostazol and thromboxane b2

cilostazol has been researched along with thromboxane b2 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikegami, T; Mizutani, M; Okuda, Y; Ueno, E; Yamashita, K1
Chijiwa, T; Igawa, T; Kato, S; Kawamura, K; Kimura, Y; Shimidzu, S; Shiragiku, T; Tani, T; Unemi, F1
Adachi, T; Ishida, K; Ito, R; Kimura, Y; Kohda, N; Marukawa, K; Matsumoto, Y; Nakayama, S; Tani, T1
Badger, SA; Lee, B; Makar, RR; McEneny, J; O'Donnell, ME; Sharif, MA; Soong, CV; Young, IS1

Trials

1 trial(s) available for cilostazol and thromboxane b2

ArticleYear
The effects of cilostazol on exercise-induced ischaemia-reperfusion injury in patients with peripheral arterial disease.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2009, Volume: 37, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Albuminuria; alpha-Tocopherol; Ascorbate Oxidase; beta Carotene; C-Reactive Protein; Cilostazol; Creatinine; Double-Blind Method; Female; Humans; Intercellular Adhesion Molecule-1; Interleukin-10; Interleukin-6; Intermittent Claudication; Lipid Peroxides; Male; Middle Aged; P-Selectin; Prospective Studies; Receptors, Tumor Necrosis Factor; Reperfusion Injury; Tetrazoles; Thromboxane B2; Vascular Cell Adhesion Molecule-1; Vasodilator Agents; Walking

2009

Other Studies

3 other study(ies) available for cilostazol and thromboxane b2

ArticleYear
Hemodynamic effects of cilostazol on peripheral artery in patients with diabetic neuropathy.
    Arzneimittel-Forschung, 1992, Volume: 42, Issue:4

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Arteries; Blood Glucose; Cilostazol; Diabetic Neuropathies; Female; Hemodynamics; Humans; Male; Middle Aged; Tetrazoles; Thromboxane B2; Vasodilator Agents

1992
Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells.
    Thrombosis research, 1990, Feb-15, Volume: 57, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Alprostadil; Azoles; Cells, Cultured; Cilostazol; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Nephelometry and Turbidimetry; Platelet Aggregation; Platelet Aggregation Inhibitors; Tetrazoles; Thromboxane B2

1990
Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery.
    Thrombosis research, 1999, Nov-15, Volume: 96, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Carotid Arteries; Cilostazol; Cyclic Nucleotide Phosphodiesterases, Type 3; Disease Models, Animal; Electric Stimulation; Endothelium, Vascular; Hemodynamics; Male; Orchiectomy; Platelet Aggregation; Serotonin; Swine; Tetrazoles; Thrombosis; Thromboxane B2; Ticlopidine

1999